Kao John E's Form 4 filing
Alignment Healthcare, Inc. (ALHC) · filed Jul 8, 2022
- Accession no.
- 0001209191-22-041712
- Filed
- Jul 8, 2022
- Trade date
- Jul 6-8, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $1.32M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kao John ECIK 0001222028 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2022 | Common Stock | SSaleDisposed | −25,752 | $13.04F2 | −$335,806.08 | 3,539,639 | Indirect | |
| Jul 7, 2022 | Common Stock | SSaleDisposed | −42,072 | $13.88F4 | −$583,959.36 | 3,497,567 | Indirect | |
| Jul 7, 2022 | Common Stock | SSaleDisposed | −7,370 | $14.29F5 | −$105,317.3 | 3,490,197 | Indirect | |
| Jul 8, 2022 | Common Stock | SSaleDisposed | −20,699 | $14.33F6 | −$296,616.67 | 3,469,498 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.00 to $13.23. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2), (4), (5) and (6) to this Form 4.
Referenced by the price of 1 transaction in Table I.
- F4
The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.15 to $14.14.
Referenced by the price of 1 transaction in Table I.
- F5
The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.16 to $14.35.
Referenced by the price of 1 transaction in Table I.
- F6
The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.10 to $14.56.
Referenced by the price of 1 transaction in Table I.